Forte Biosciences Inc.
16.64
2.02 (13.82%)
At close: Jan 15, 2025, 3:59 PM
16.50
-0.84%
After-hours Jan 15, 2025, 04:00 PM EST

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
PE Ratio -0.82 -1.25 -1.38 -3.41 -4.15 -3.36 -3.85 -7.35 -9.85
PS Ratio n/a n/a n/a n/a n/a 9.13 3.65K 5.02K 4.45K
PB Ratio 0.73 0.45 0.72 4.54 -3.54 2.83 2.11 35.19 5.81
P/FCF Ratio -0.9 -2.12 -1.79 -14.54 -5.75 -4.52 -4.71 -8.19 -10.67
P/OCF Ratio -0.9 -2.12 -1.79 -14.54 -6.09 -4.78 -4.81 -8.34 -10.79
OCF/S Ratio n/a n/a n/a n/a n/a -1.91 -759.34 -602.84 -412.59
Debt / Equity Ratio n/a n/a n/a n/a -1.84 0.45 0.15 3.00 0.45
Quick Ratio 10.45 13.06 24.19 26.52 3.93 5.91 5.23 2.26 10.14
Current Ratio 10.45 13.06 24.19 26.52 3.93 5.91 5.23 2.26 10.14
Asset Turnover n/a n/a n/a n/a n/a 0.17 0.00 0.00 0.00
Interest Coverage n/a n/a n/a n/a n/a -264.47 -19.48 17.25 225.04
Return on Equity (ROE) -0.89 -0.36 -0.52 -1.33 0.85 -0.84 -0.55 -4.79 -0.59
Return on Assets (ROA) -0.81 -0.33 -0.5 -1.28 -0.53 -0.47 -0.42 -0.95 -0.37
Return on Capital (ROIC) -0.92 -0.36 -0.52 0.30 -0.71 -0.53 -0.5 -1.51 -0.41
Dividend Yield n/a n/a n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a n/a n/a 100.00% 100.00% 100.00% 100.00%
Net Profit Margin n/a n/a n/a n/a n/a -271.43% -94.95K% -68.32K% -45.21K%
Pretax Profit Margin n/a n/a n/a n/a n/a -262.01% -94.95K% -68.32K% -45.21K%
Operating Profit Margin n/a n/a n/a n/a n/a -254.23% -91.78K% -64.68K% -45.01K%
FCF Margin n/a n/a n/a n/a n/a -202.02% -77.53K% -61.36K% -41.71K%
EBITDA Margin n/a n/a n/a n/a n/a -242.26% -89.52K% -63.61K% -44.09K%